佰仁医疗: insider trades · France · AMF SSE:688198 FR FR · AMF Mcap 14.7Bn€
Discover the full insider trade history of 佰仁医疗, a listed issuer based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €14.7bn. The latest transaction was reported on 2 January 2025 (Purchase). Among the most active insiders: 吴嘉. Every trade is openly available.
€138,684
12 ops.
Sell Volume
Financial data FY ended December 2025 · cache
Income statement
Revenue 620.2 M€
Gross profit 553.1 M€ 89% margin
Net income 193.6 M€ 31.2% margin
Balance sheet & cash
Market cap 14.74 Bn€
Total debt 93.6 M€
Free Cash Flow 61.6 M€
Last declaration on 2 January 2025
Declarations 18 total
Executives ● Purchase7 SSE
€215,247 15,200 shares
SSE:173000008396299330 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Sale2 SSE
€22,412 1,500 shares
SSE:173000008377200740 · 25 Dec 2024
Executives ● Sale2 SSE
€39,270 2,604 shares
SSE:173000008362519260 · 18 Dec 2024
Executives ● Sale2 SSE
€31,477 2,000 shares
SSE:173000008342197060 · 10 Dec 2024
Executives ● Purchase10 SSE
€182,805 12,000 shares
SSE:173000008276334940 · 18 Nov 2024
Ideal exit: 15 Aug 2025 (T+270) Executives ● Sale2 SSE
€6,066 500 shares
SSE:173000008115074600 · 20 Sept 2024
Executives ● Sale2 SSE
€39,459 3,000 shares
SSE:173000007779597020 · 20 Jun 2024
Executives ● Sale2 SSE
1,500 shares
SSE:173000007105043170 · 20 Nov 2023
Executives ● Sale2 SSE
2,000 shares
SSE:173000006758729660 · 25 Jul 2023
Executives ● Sale2 SSE
800 shares
SSE:173000006747735740 · 19 Jul 2023
Executives ● Sale2 SSE
1,000 shares
SSE:173000005986370750 · 26 Oct 2022
Executives ● Sale2 SSE
2,000 shares
SSE:173000005730496320 · 28 Jul 2022
Executives ● Purchase10 SSE
10,000 shares
SSE:173000005588899000 · 13 Jun 2022
Ideal exit: 10 Mar 2023 (T+270) Executives ● Purchase10 SSE
9,100 shares
SSE:173000005578585860 · 7 Jun 2022
Ideal exit: 4 Mar 2023 (T+270) Executives ● Purchase7 SSE
3,716 shares
SSE:173000005573936450 · 6 Jun 2022
Ideal exit: 3 Mar 2023 (T+270) Executives ● Purchase7 SSE
6,084 shares
SSE:173000005560699740 · 31 May 2022
Ideal exit: 25 Feb 2023 (T+270) Executives ● Sale2 SSE
1,000 shares
SSE:173000005426679940 · 18 Mar 2022
Executives ● Sale2 SSE
200 shares
SSE:173000005426679900 · 10 Sept 2021
